In April 2025, at a time when the market was rather in turmoil, I published my last article about CVS Health Corporation (NYSE: CVS ), which was titled “Maybe The Right Investment AtMy analysis is focused on high-quality companies, that can outperform the market over the long-run due to a competitive advantage (economic moat) and high levels of defensibility. Focused on European and North American companies, but without constraints regarding market capitalization (from large cap to small cap companies).My a ...